• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎患者发生静脉血栓栓塞的风险

Risk of venous thromboembolism with rheumatoid arthritis.

作者信息

Matta Fadi, Singala Ravinder, Yaekoub Abdo Y, Najjar Reiad, Stein Paul D

机构信息

Saint Joseph Mercy Oakland, 44405 Woodward Avenue, Pontiac, MI 48341-5023, USA.

出版信息

Thromb Haemost. 2009 Jan;101(1):134-8.

PMID:19132199
Abstract

Rheumatoid arthritis is not generally considered to be a risk factor for venous thromboembolism (VTE), although abnormalities of coagulation factors have been found in patients with rheumatoid arthritis. Sparse data in a few patients suggest that patients with rheumatoid arthritis may have higher rates of VTE. The purpose of this investigation was to determine if the incidences of pulmonary embolism (PE) and deep venous thrombosis (DVT) are increased in hospitalized patients with rheumatoid arthritis. The number of patients discharged from non-Federal short-stay hospitals throughout the United States from 1979 through 2005 with a discharge code for rheumatoid arthritis was obtained from the National Hospital Discharge Survey (NHDS). Among hospitalized patients with rheumatoid arthritis who did not have joint surgery, 41,000 of 4,818,000 (0.85%) had PE compared with 3,366,000 of 891,055,000 (0.38%) among patients who did not have rheumatoid arthritis and who did not have operations or joint surgery (relative risk = 2.25). Deep venous thrombosis was diagnosed in 79,000 of 4,818,000 (1.64%) patients with rheumatoid arthritis and no joint operation, versus 7,681,000 of 891,055,000 (0.86%) who did not have rheumatoid arthritis or a joint operation (relative risk = 1.90). The relative risk of venous thromboembolism (PE and/or DVT) in these patients was 1.99. The data suggest that rheumatoid arthritis is a risk factor for VTE in hospitalized medical patients. A heightened awareness of the risks for VTE and a lower threshold for evaluation of patients for possible DVT or PE would be appropriate in caring for hospitalized patients with rheumatoid arthritis.

摘要

类风湿性关节炎一般不被视为静脉血栓栓塞(VTE)的危险因素,尽管在类风湿性关节炎患者中已发现凝血因子异常。少数患者的稀疏数据表明,类风湿性关节炎患者可能有更高的VTE发生率。本研究的目的是确定类风湿性关节炎住院患者中肺栓塞(PE)和深静脉血栓形成(DVT)的发生率是否增加。从1979年至2005年美国各地非联邦短期住院医院出院且出院诊断代码为类风湿性关节炎的患者数量,是从国家医院出院调查(NHDS)中获取的。在没有进行关节手术的类风湿性关节炎住院患者中,481.8万例中有4.1万例(0.85%)发生了PE,而在没有类风湿性关节炎且没有进行手术或关节手术的患者中,89105.5万例中有336.6万例(0.38%)发生了PE(相对风险 = 2.25)。在481.8万例没有进行关节手术的类风湿性关节炎患者中,有7.9万例(1.64%)被诊断为深静脉血栓形成,而在没有类风湿性关节炎或关节手术的89105.5万例患者中,有768.1万例(0.86%)被诊断为深静脉血栓形成(相对风险 = 1.90)。这些患者发生静脉血栓栓塞(PE和/或DVT)的相对风险为1.99。数据表明,类风湿性关节炎是内科住院患者发生VTE的危险因素。在护理类风湿性关节炎住院患者时,提高对VTE风险的认识并降低对可能发生DVT或PE患者的评估阈值是合适的。

相似文献

1
Risk of venous thromboembolism with rheumatoid arthritis.类风湿关节炎患者发生静脉血栓栓塞的风险
Thromb Haemost. 2009 Jan;101(1):134-8.
2
Racial, biological sex, and geographic disparities of venous thromboembolism in the United States, 2016 to 2019.美国 2016 至 2019 年静脉血栓栓塞的种族、生物性别和地域差异。
J Vasc Surg Venous Lymphat Disord. 2024 Sep;12(5):101908. doi: 10.1016/j.jvsv.2024.101908. Epub 2024 May 15.
3
The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study.类风湿关节炎患者肺栓塞和深静脉血栓形成的风险和趋势:一项基于普通人群的研究。
Rheumatology (Oxford). 2021 Jan 5;60(1):188-195. doi: 10.1093/rheumatology/keaa262.
4
Venous thromboembolism incidence in upper limb orthopedic surgery: do these procedures increase venous thromboembolism risk?上肢骨科手术中的静脉血栓栓塞发生率:这些手术会增加静脉血栓栓塞风险吗?
J Shoulder Elbow Surg. 2014 Oct;23(10):1481-4. doi: 10.1016/j.jse.2014.01.044. Epub 2014 Apr 18.
5
Venous thromboembolism in patients hospitalized with thyroid dysfunction.住院甲状腺功能障碍患者的静脉血栓栓塞症。
Clin Appl Thromb Hemost. 2009 Dec;15(6):676-80. doi: 10.1177/1076029609336856. Epub 2009 Aug 10.
6
Human immunodeficiency virus infection and risk of venous thromboembolism.人类免疫缺陷病毒感染与静脉血栓栓塞风险
Am J Med Sci. 2008 Nov;336(5):402-6. doi: 10.1097/MAJ.0b013e31816dd2fd.
7
The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States.美国住院患者静脉血栓栓塞症的发病率及经济负担
J Arthroplasty. 2017 Apr;32(4):1063-1066. doi: 10.1016/j.arth.2016.10.020. Epub 2016 Oct 21.
8
Prevalence and countermeasures for venous thromboembolic diseases associated with spinal surgery: a follow-up study of an institutional protocol in 209 patients.脊柱手术相关静脉血栓栓塞性疾病的患病率及对策:一项针对209例患者机构方案的随访研究
Spine (Phila Pa 1976). 2014 May 1;39(10):791-7. doi: 10.1097/BRS.0000000000000295.
9
Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population.静脉血栓栓塞症:神经外科人群中的深静脉血栓形成和肺栓塞。
J Neurosurg. 2011 Jan;114(1):40-6. doi: 10.3171/2010.8.JNS10332. Epub 2010 Sep 3.
10
Incidence and prevention of postoperative venous thromboembolism: are they meaningful quality indicators in Japanese health care settings?术后静脉血栓栓塞的发生率和预防:它们在日本的医疗保健环境中是有意义的质量指标吗?
World J Surg. 2012 Feb;36(2):280-6. doi: 10.1007/s00268-011-1229-x.

引用本文的文献

1
[Incidence and risk factors of deep vein thrombosis in patients with rheumatoid arthritis].[类风湿关节炎患者深静脉血栓形成的发病率及危险因素]
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Apr 18;56(2):279-283. doi: 10.19723/j.issn.1671-167X.2024.02.012.
2
Risk of venous thromboembolism in patients with rheumatoid arthritis: a meta-analysis of observational studies.类风湿关节炎患者发生静脉血栓栓塞的风险:观察性研究的荟萃分析
BMC Rheumatol. 2024 Feb 2;8(1):5. doi: 10.1186/s41927-024-00376-9.
3
Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis.
炎症性免疫疾病中使用 Janus 激酶抑制剂引发静脉血栓栓塞的风险:一项系统评价与荟萃分析
Front Pharmacol. 2023 Jun 7;14:1189389. doi: 10.3389/fphar.2023.1189389. eCollection 2023.
4
[Clinical characteristics of patients with rheumatoid arthritis complicated with venous thrombosis of lower extremities].类风湿关节炎合并下肢静脉血栓形成患者的临床特征
Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Dec 18;54(6):1079-1085. doi: 10.19723/j.issn.1671-167X.2022.06.004.
5
Rates, Reasons, and Independent Predictors of Readmissions in Portal Venous Thrombosis Hospitalizations in the USA.美国门静脉血栓形成住院再入院率、原因及独立预测因素
Gastroenterology Res. 2022 Oct;15(5):253-262. doi: 10.14740/gr1561. Epub 2022 Oct 19.
6
Venous Thromboembolism in Rheumatoid Arthritis: The Added Effect of Disease Activity to Traditional Risk Factors.类风湿关节炎中的静脉血栓栓塞:疾病活动度对传统危险因素的附加影响。
Open Access Rheumatol. 2022 Oct 17;14:231-242. doi: 10.2147/OARRR.S284757. eCollection 2022.
7
Oral Janus kinase inhibitors and venous thromboembolic events in atopic dermatitis: protocols for a case-time control study and a nested case-control study based on the French national health insurance (SNDS) cohort.口服 JAK 抑制剂与特应性皮炎的静脉血栓栓塞事件:基于法国国家健康保险(SNDS)队列的病例时间对照研究和巢式病例对照研究方案。
BMJ Open. 2022 Sep 21;12(9):e059979. doi: 10.1136/bmjopen-2021-059979.
8
The effect of emerging tobacco related products and their toxic constituents on thrombosis.新兴烟草相关产品及其有毒成分对血栓形成的影响。
Life Sci. 2022 Feb 1;290:120255. doi: 10.1016/j.lfs.2021.120255. Epub 2021 Dec 23.
9
Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review.与类风湿关节炎相关的 Janus 激酶抑制剂的静脉血栓栓塞风险:病例报告和文献复习。
Clin Rheumatol. 2021 Nov;40(11):4457-4471. doi: 10.1007/s10067-021-05911-4. Epub 2021 Sep 23.
10
Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF-06826647: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study.口服 TYK2 抑制剂 PF-06826647 的安全性和药代动力学:一项 I 期、随机、双盲、安慰剂对照、剂量递增研究。
Clin Transl Sci. 2021 Mar;14(2):671-682. doi: 10.1111/cts.12929. Epub 2020 Dec 8.